Recent investigations have focused on the overlap of GLP|GIP|GCGR stimulant therapies and dopamine neurotransmission. While GLP stimulators are widely employed for addressing type 2 diabetes, their emerging effects on reinforcement circuits, specifically influenced by dopaminergic networks, are attracting considerable attention. This report prov… Read More